ResMed (NYSE: RMD, ASX: RMD) this week announced the grand opening of its new Advanced Manufacturing Center in Singapore’s Tuas area.
The new 270,000-square-foot facility doubles the respiratory care company’s presence in Singapore to serve its key manufacturing hub in Asia Pacific. The facility will employ nearly 1,000 people and has smart dashboards that integrate real-time data to monitor the performance of production lines.
ResMed’s new facility also has the manufacturing capacity and footprint to scale production for connected devices and mask systems. The company plans to use the new facility to produce its latest positive airway pressure (PAP) system, which allows users to monitor their own sleep apnea treatment.
“Singapore’s strategic location and support for business investment, coupled with ResMed’s world-leading devices and digital health offerings, provides the perfect opportunity to expand our manufacturing capabilities while supporting local jobs and the region’s economy,” CEO Mick Farrell said in a news release. “The opening of this facility supports the continued growth of ResMed’s product portfolio to meet the needs of millions of people across Singapore, Asia-Pacific, and the world.”
The newest Singapore-based manufacturing center is just one of a few new medtech facilities opening in the region. Earlier this month, Smith+Nephew opened a major medical education and digital innovation center to cover the Asia-Pacific region. Olympus’ Evident also opened its Asia-Pacific headquarters in Singapore in October.
“This facility marks a major milestone for ResMed, both in your growth as a world-leading medical device company, and in the expansion of your footprint in Singapore. I am glad ResMed has chosen Singapore as your partner in innovation and growth,” said Senior Minister Tharman Shanmugaratnam.